Immune-Based Antitumor Effects of BRAF Inhibitors Rely on Signaling by CD40L and IFNγ (Q33776925)
scientific article published on April 15, 2014
Language:
(P31) (Q13442814)
(P50) (Q87309012)
(P304) 3205-3217
(P407) (Q1860)
(P433) 12
(P478) 74
(P577) Tuesday, April 15, 2014
(P953) https://cancerres.aacrjournals.org/content/canres/74/12/3205.full.pdf
https://europepmc.org/articles/PMC4063281
https://europepmc.org/articles/PMC4063281?pdf=render
https://doi.org/10.1158/0008-5472.can-13-3461
https://aacrjournals.org/cancerres/article-pdf/74/12/3205/2702640/3205.pdf
(P1433) (Q326097)
(P1476) "Immune-Based Antitumor Effects of BRAF Inhibitors Rely on Signaling by CD40L and IFNγ" (language: en)
(P2093) Yao-Chen Tsui
Bhaskar Srivastava
Katrina M. Meeth
Marcus W. Bosenberg
Susan M. Kaech
(P2860) (Q37257207)
(Q27852310)
(Q36793408)
(Q37038401)
(Q39175189)
(Q36793719)
(Q36664195)
(Q36638192)
(Q38078136)
(Q39212469)
(Q36711431)
(Q33996674)
(Q39254036)
(Q28276886)
(Q24632064)
(Q36194822)
(Q39304634)
(Q33768093)
(Q38020632)
(Q36175312)
(Q42250522)
(Q37996703)
(Q24594790)
(Q37150560)
(Q35642044)
(Q35621787)
(Q35578622)
(Q29620351)
(Q35015778)
(Q29614348)
(Q37809156)
(Q34346803)
(Q30430481)
(Q39692699)
(Q33746583)
(Q33730129)
(Q30433070)
(Q39873596)
(Q24653754)
(Q24633445)
(Q51970485)
(Q36065955)
(Q36027441)
(Q44539245)
(Q43418999)
(Q47573472)
(Q43591261)
(Q44285227)
(Q57080098)
(Q85102157)
other details
description scientific article published on April 15, 2014

External Links